Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypothyroidism | 34 | 2023 | 669 | 9.220 |
Why?
|
Thyroxine | 34 | 2023 | 665 | 8.560 |
Why?
|
Thyroid Gland | 15 | 2021 | 1172 | 2.460 |
Why?
|
Thyrotropin | 18 | 2023 | 834 | 2.110 |
Why?
|
Triiodothyronine | 12 | 2023 | 492 | 1.790 |
Why?
|
Thyroid Diseases | 6 | 2018 | 387 | 1.670 |
Why?
|
Thyroid Hormones | 11 | 2023 | 407 | 1.650 |
Why?
|
Thyroid Nodule | 7 | 2021 | 767 | 1.460 |
Why?
|
Iodine Radioisotopes | 11 | 2015 | 1035 | 1.440 |
Why?
|
Thyroid Function Tests | 11 | 2021 | 289 | 1.400 |
Why?
|
Hormone Replacement Therapy | 6 | 2018 | 756 | 1.190 |
Why?
|
Thyroid Neoplasms | 11 | 2021 | 2360 | 1.190 |
Why?
|
Tissue Extracts | 2 | 2017 | 139 | 1.030 |
Why?
|
Drugs, Generic | 3 | 2022 | 454 | 1.010 |
Why?
|
Biopsy, Fine-Needle | 8 | 2021 | 1132 | 0.920 |
Why?
|
Endocrinology | 5 | 2019 | 443 | 0.810 |
Why?
|
Iodine | 3 | 2015 | 286 | 0.710 |
Why?
|
Thyrotoxicosis | 5 | 2016 | 85 | 0.690 |
Why?
|
Hyperthyroidism | 5 | 2013 | 295 | 0.640 |
Why?
|
Thyroiditis, Autoimmune | 1 | 2018 | 102 | 0.600 |
Why?
|
Graves Disease | 5 | 2013 | 239 | 0.530 |
Why?
|
Therapeutic Equivalency | 6 | 2022 | 134 | 0.500 |
Why?
|
Congenital Hypothyroidism | 1 | 2013 | 40 | 0.420 |
Why?
|
Lubricants | 1 | 2012 | 26 | 0.420 |
Why?
|
Mass Screening | 4 | 2016 | 5451 | 0.400 |
Why?
|
Adenocarcinoma, Follicular | 3 | 2021 | 326 | 0.390 |
Why?
|
Biopsy, Needle | 2 | 2012 | 1627 | 0.380 |
Why?
|
Thyroiditis | 1 | 2011 | 86 | 0.370 |
Why?
|
Vaginal Smears | 1 | 2012 | 505 | 0.330 |
Why?
|
Disease Management | 3 | 2015 | 2537 | 0.330 |
Why?
|
History, 19th Century | 3 | 2019 | 715 | 0.320 |
Why?
|
Receptors, Thyrotropin | 1 | 2009 | 45 | 0.320 |
Why?
|
Documentation | 1 | 2015 | 917 | 0.310 |
Why?
|
Humans | 85 | 2023 | 768393 | 0.300 |
Why?
|
Radiation Protection | 1 | 2012 | 428 | 0.300 |
Why?
|
History, 21st Century | 4 | 2019 | 1575 | 0.300 |
Why?
|
Cytodiagnosis | 3 | 2021 | 453 | 0.290 |
Why?
|
Drug Compounding | 2 | 2020 | 243 | 0.290 |
Why?
|
Carcinoma | 2 | 2016 | 2341 | 0.290 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2021 | 8634 | 0.280 |
Why?
|
Practice Guidelines as Topic | 6 | 2018 | 7453 | 0.280 |
Why?
|
Veterans | 1 | 2020 | 2671 | 0.270 |
Why?
|
Lithium Compounds | 1 | 2008 | 226 | 0.270 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2296 | 0.270 |
Why?
|
Carcinoma, Papillary | 4 | 2021 | 793 | 0.260 |
Why?
|
History, 20th Century | 4 | 2019 | 2771 | 0.260 |
Why?
|
Tomography, Emission-Computed | 1 | 2009 | 1126 | 0.260 |
Why?
|
Depressive Disorder | 1 | 2018 | 3736 | 0.250 |
Why?
|
Quality Assurance, Health Care | 1 | 2016 | 2181 | 0.250 |
Why?
|
Evidence-Based Medicine | 2 | 2016 | 3707 | 0.250 |
Why?
|
United States Food and Drug Administration | 5 | 2019 | 1672 | 0.230 |
Why?
|
Atherosclerosis | 1 | 2020 | 3431 | 0.220 |
Why?
|
Goiter | 2 | 2013 | 87 | 0.220 |
Why?
|
Drug Therapy | 1 | 2006 | 504 | 0.210 |
Why?
|
Muscle Weakness | 2 | 2005 | 415 | 0.200 |
Why?
|
Renal Insufficiency | 1 | 2008 | 809 | 0.200 |
Why?
|
Epitopes | 1 | 2009 | 2525 | 0.200 |
Why?
|
Growth Hormone | 2 | 2001 | 573 | 0.190 |
Why?
|
Iodide Peroxidase | 1 | 2023 | 295 | 0.190 |
Why?
|
Diet | 3 | 2015 | 8090 | 0.190 |
Why?
|
Carnitine | 2 | 2005 | 254 | 0.190 |
Why?
|
Adenocarcinoma, Papillary | 1 | 2021 | 86 | 0.180 |
Why?
|
Dosage Forms | 1 | 2020 | 56 | 0.180 |
Why?
|
Weight Lifting | 1 | 2001 | 130 | 0.180 |
Why?
|
Quality Improvement | 1 | 2016 | 3858 | 0.180 |
Why?
|
Drug Administration Routes | 1 | 2020 | 151 | 0.180 |
Why?
|
Endocrine Glands | 1 | 2010 | 101 | 0.180 |
Why?
|
Chemistry, Pharmaceutical | 3 | 2008 | 275 | 0.180 |
Why?
|
Tablets | 1 | 2020 | 149 | 0.170 |
Why?
|
Egypt | 1 | 2020 | 100 | 0.170 |
Why?
|
Clinical Medicine | 1 | 2021 | 145 | 0.170 |
Why?
|
Drug Substitution | 1 | 2022 | 291 | 0.170 |
Why?
|
Gels | 1 | 2020 | 421 | 0.160 |
Why?
|
Carcinoma, Papillary, Follicular | 1 | 2019 | 59 | 0.160 |
Why?
|
Endocrine System Diseases | 1 | 2010 | 250 | 0.150 |
Why?
|
Drug Therapy, Combination | 3 | 2018 | 6318 | 0.150 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2001 | 552 | 0.150 |
Why?
|
Potassium Iodide | 1 | 2017 | 13 | 0.150 |
Why?
|
Radioactive Hazard Release | 1 | 2017 | 13 | 0.150 |
Why?
|
Retrospective Studies | 8 | 2021 | 81801 | 0.140 |
Why?
|
Creatinine | 2 | 2004 | 1915 | 0.140 |
Why?
|
Thyroid (USP) | 1 | 2016 | 3 | 0.140 |
Why?
|
Intestinal Absorption | 1 | 2018 | 400 | 0.140 |
Why?
|
Immunoassay | 1 | 2020 | 745 | 0.140 |
Why?
|
Pituitary Neoplasms | 2 | 1996 | 1325 | 0.140 |
Why?
|
Hashimoto Disease | 2 | 2013 | 108 | 0.130 |
Why?
|
Goals | 1 | 2021 | 716 | 0.130 |
Why?
|
Managed Care Programs | 1 | 2021 | 942 | 0.130 |
Why?
|
Suction | 1 | 1997 | 268 | 0.130 |
Why?
|
Fasting | 2 | 2020 | 1610 | 0.130 |
Why?
|
Frail Elderly | 1 | 2001 | 775 | 0.130 |
Why?
|
Societies, Scientific | 1 | 2016 | 223 | 0.130 |
Why?
|
Adrenocorticotropic Hormone | 1 | 1997 | 619 | 0.130 |
Why?
|
Milk | 1 | 2018 | 443 | 0.120 |
Why?
|
Oxyphil Cells | 1 | 2015 | 56 | 0.120 |
Why?
|
History, Ancient | 1 | 2015 | 213 | 0.120 |
Why?
|
Female | 33 | 2021 | 397089 | 0.120 |
Why?
|
United States | 12 | 2019 | 73150 | 0.120 |
Why?
|
Male | 27 | 2021 | 364902 | 0.110 |
Why?
|
Preventive Medicine | 1 | 2016 | 246 | 0.110 |
Why?
|
Exercise Therapy | 1 | 2001 | 941 | 0.110 |
Why?
|
Biological Availability | 2 | 2006 | 392 | 0.110 |
Why?
|
Glyburide | 1 | 1994 | 117 | 0.110 |
Why?
|
Societies, Medical | 4 | 2018 | 3960 | 0.110 |
Why?
|
Biological Assay | 1 | 2016 | 627 | 0.110 |
Why?
|
Diabetic Angiopathies | 1 | 1998 | 806 | 0.110 |
Why?
|
Mental Disorders | 1 | 2013 | 6876 | 0.110 |
Why?
|
Ultrasonography | 2 | 2020 | 6001 | 0.110 |
Why?
|
Eating | 1 | 2020 | 1541 | 0.110 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2017 | 495 | 0.110 |
Why?
|
Thyroidectomy | 2 | 2016 | 914 | 0.110 |
Why?
|
Aged | 17 | 2021 | 171562 | 0.100 |
Why?
|
Adult | 22 | 2021 | 223640 | 0.100 |
Why?
|
Data Collection | 2 | 2014 | 3324 | 0.100 |
Why?
|
Patient Education as Topic | 1 | 2013 | 2337 | 0.100 |
Why?
|
Middle Aged | 20 | 2021 | 223491 | 0.100 |
Why?
|
Administration, Oral | 1 | 2020 | 4039 | 0.100 |
Why?
|
Muscles | 1 | 1997 | 1582 | 0.100 |
Why?
|
Asymptomatic Diseases | 1 | 2015 | 589 | 0.100 |
Why?
|
Thermogenesis | 1 | 2016 | 494 | 0.100 |
Why?
|
Drug Interactions | 1 | 2016 | 1420 | 0.100 |
Why?
|
Acromegaly | 1 | 1995 | 316 | 0.100 |
Why?
|
Cerebrovascular Disorders | 1 | 1998 | 1486 | 0.100 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2015 | 342 | 0.090 |
Why?
|
T-Lymphocytes | 1 | 2009 | 10267 | 0.090 |
Why?
|
Guideline Adherence | 3 | 2019 | 2240 | 0.090 |
Why?
|
Diagnosis, Differential | 6 | 2019 | 13020 | 0.090 |
Why?
|
Adipose Tissue, Brown | 1 | 2016 | 776 | 0.090 |
Why?
|
Nutrition Policy | 1 | 2014 | 467 | 0.090 |
Why?
|
Cell Nucleus | 1 | 2019 | 2886 | 0.090 |
Why?
|
Disease Progression | 3 | 2015 | 13646 | 0.090 |
Why?
|
Ambulatory Care Facilities | 1 | 2016 | 941 | 0.080 |
Why?
|
Reproducibility of Results | 2 | 2023 | 20224 | 0.080 |
Why?
|
Combined Modality Therapy | 3 | 2015 | 8562 | 0.080 |
Why?
|
Morbidity | 1 | 2014 | 1758 | 0.080 |
Why?
|
Risk Factors | 5 | 2020 | 74962 | 0.080 |
Why?
|
Aged, 80 and over | 7 | 2021 | 59686 | 0.080 |
Why?
|
Genetic Testing | 1 | 2021 | 3587 | 0.070 |
Why?
|
Medical Audit | 1 | 2009 | 454 | 0.070 |
Why?
|
Hyperprolactinemia | 1 | 1988 | 124 | 0.070 |
Why?
|
Cost Savings | 1 | 2012 | 915 | 0.070 |
Why?
|
Anxiety Disorders | 1 | 2018 | 2754 | 0.070 |
Why?
|
Drug Stability | 2 | 2008 | 291 | 0.070 |
Why?
|
Treatment Outcome | 5 | 2021 | 65379 | 0.070 |
Why?
|
Self Report | 1 | 2018 | 3766 | 0.070 |
Why?
|
Quality Indicators, Health Care | 1 | 2016 | 1813 | 0.060 |
Why?
|
Pregnancy | 5 | 2021 | 30200 | 0.060 |
Why?
|
Predictive Value of Tests | 3 | 2019 | 15455 | 0.060 |
Why?
|
Adenoma | 1 | 1996 | 2163 | 0.060 |
Why?
|
Patient Satisfaction | 1 | 2018 | 3486 | 0.060 |
Why?
|
Kidney | 1 | 2020 | 7064 | 0.060 |
Why?
|
Mood Disorders | 1 | 2012 | 1129 | 0.060 |
Why?
|
Prognosis | 3 | 2016 | 30022 | 0.060 |
Why?
|
Databases, Factual | 1 | 2020 | 8075 | 0.060 |
Why?
|
Family Practice | 1 | 2007 | 511 | 0.060 |
Why?
|
Quality of Life | 2 | 2023 | 13503 | 0.060 |
Why?
|
Deficiency Diseases | 1 | 2004 | 74 | 0.050 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2008 | 628 | 0.050 |
Why?
|
Insurance Benefits | 1 | 2005 | 187 | 0.050 |
Why?
|
Legislation, Drug | 1 | 2005 | 216 | 0.050 |
Why?
|
Risk Assessment | 2 | 2021 | 24318 | 0.050 |
Why?
|
Prevalence | 2 | 2019 | 15872 | 0.050 |
Why?
|
Dietary Supplements | 1 | 2015 | 3443 | 0.050 |
Why?
|
Age Factors | 2 | 2014 | 18471 | 0.050 |
Why?
|
Radiopharmaceuticals | 1 | 2012 | 2734 | 0.050 |
Why?
|
Depression | 2 | 2018 | 8241 | 0.050 |
Why?
|
Clinical Protocols | 1 | 2007 | 1445 | 0.050 |
Why?
|
Drug Monitoring | 1 | 2007 | 964 | 0.050 |
Why?
|
Muscular Diseases | 1 | 2005 | 554 | 0.050 |
Why?
|
Drug Approval | 1 | 2008 | 818 | 0.050 |
Why?
|
Cohort Studies | 2 | 2020 | 41795 | 0.040 |
Why?
|
Animals | 5 | 2018 | 169337 | 0.040 |
Why?
|
Body Composition | 2 | 2001 | 2461 | 0.040 |
Why?
|
Injections, Subcutaneous | 1 | 2001 | 687 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 1998 | 6567 | 0.040 |
Why?
|
Academic Medical Centers | 1 | 2009 | 2783 | 0.040 |
Why?
|
Prefrontal Cortex | 1 | 2008 | 2257 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2012 | 3985 | 0.040 |
Why?
|
Nuclear Power Plants | 1 | 2017 | 13 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15939 | 0.040 |
Why?
|
Artificial Organs | 1 | 1999 | 149 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2006 | 10776 | 0.040 |
Why?
|
Muscle, Skeletal | 2 | 2005 | 4981 | 0.040 |
Why?
|
Young Adult | 3 | 2016 | 60049 | 0.040 |
Why?
|
Double-Blind Method | 3 | 2007 | 12456 | 0.030 |
Why?
|
Body Weight | 2 | 2004 | 4629 | 0.030 |
Why?
|
Drug Costs | 1 | 2005 | 1196 | 0.030 |
Why?
|
Recombinant Proteins | 2 | 2004 | 6510 | 0.030 |
Why?
|
Referral and Consultation | 1 | 2009 | 3627 | 0.030 |
Why?
|
Thyrotropin-Releasing Hormone | 2 | 1986 | 139 | 0.030 |
Why?
|
Paraneoplastic Endocrine Syndromes | 1 | 1995 | 29 | 0.030 |
Why?
|
Hormones, Ectopic | 1 | 1995 | 37 | 0.030 |
Why?
|
Iatrogenic Disease | 1 | 1999 | 552 | 0.030 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2009 | 3112 | 0.030 |
Why?
|
Professional Competence | 1 | 2018 | 430 | 0.030 |
Why?
|
Antidepressive Agents | 1 | 2007 | 2913 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2003 | 1088 | 0.030 |
Why?
|
Radionuclide Imaging | 1 | 1999 | 1998 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 1998 | 12241 | 0.030 |
Why?
|
Regression Analysis | 1 | 2004 | 6350 | 0.030 |
Why?
|
Advisory Committees | 1 | 2018 | 797 | 0.030 |
Why?
|
Insulin-Like Growth Factor II | 1 | 1995 | 268 | 0.030 |
Why?
|
Adenoma, Oxyphilic | 1 | 2015 | 152 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2001 | 1422 | 0.030 |
Why?
|
Biopsy | 2 | 2005 | 6808 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2001 | 1943 | 0.030 |
Why?
|
Pituitary Gland | 1 | 1996 | 634 | 0.030 |
Why?
|
Time Factors | 3 | 2004 | 40272 | 0.030 |
Why?
|
Education, Medical, Continuing | 1 | 1998 | 829 | 0.030 |
Why?
|
Adolescent | 5 | 2009 | 89184 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2001 | 6241 | 0.030 |
Why?
|
Radiography | 1 | 2004 | 6993 | 0.030 |
Why?
|
Comorbidity | 1 | 2007 | 10588 | 0.030 |
Why?
|
Postpartum Thyroiditis | 1 | 2011 | 1 | 0.020 |
Why?
|
Recurrence | 1 | 2004 | 8506 | 0.020 |
Why?
|
Disasters | 1 | 2017 | 523 | 0.020 |
Why?
|
Bipolar Disorder | 1 | 2008 | 5126 | 0.020 |
Why?
|
Fatigue | 1 | 2018 | 1555 | 0.020 |
Why?
|
Affect | 1 | 2018 | 1501 | 0.020 |
Why?
|
Placebos | 1 | 1994 | 1668 | 0.020 |
Why?
|
Pleural Neoplasms | 1 | 1995 | 612 | 0.020 |
Why?
|
Algorithms | 2 | 2007 | 14154 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2013 | 3267 | 0.020 |
Why?
|
Interleukin-7 Receptor alpha Subunit | 1 | 2009 | 50 | 0.020 |
Why?
|
Pilot Projects | 2 | 2016 | 8731 | 0.020 |
Why?
|
Depressive Disorder, Major | 1 | 2007 | 4819 | 0.020 |
Why?
|
Equipment Design | 1 | 1997 | 3529 | 0.020 |
Why?
|
Mesothelioma | 1 | 1995 | 811 | 0.020 |
Why?
|
Drug Storage | 1 | 2008 | 52 | 0.020 |
Why?
|
Evidence-Based Practice | 1 | 2012 | 500 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2016 | 2056 | 0.020 |
Why?
|
Hypoglycemia | 1 | 1995 | 894 | 0.020 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2009 | 306 | 0.020 |
Why?
|
Coronary Vessels | 1 | 1998 | 3125 | 0.020 |
Why?
|
Alzheimer Disease | 1 | 2008 | 8747 | 0.020 |
Why?
|
Swine | 1 | 1997 | 5994 | 0.020 |
Why?
|
Life Style | 1 | 1998 | 3929 | 0.020 |
Why?
|
Models, Biological | 1 | 2013 | 9493 | 0.020 |
Why?
|
Emotions | 1 | 2018 | 2768 | 0.020 |
Why?
|
Internet | 1 | 2018 | 3107 | 0.020 |
Why?
|
Body Surface Area | 1 | 1986 | 206 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2016 | 2906 | 0.020 |
Why?
|
Linear Models | 1 | 1995 | 5878 | 0.010 |
Why?
|
Autopsy | 1 | 2008 | 1013 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 4047 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 1994 | 2588 | 0.010 |
Why?
|
Drug Synergism | 1 | 2007 | 1762 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9636 | 0.010 |
Why?
|
Consensus | 1 | 2012 | 3212 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2007 | 15649 | 0.010 |
Why?
|
Public Health | 1 | 2014 | 2682 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 1996 | 11254 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 1995 | 2972 | 0.010 |
Why?
|
Half-Life | 1 | 2001 | 650 | 0.010 |
Why?
|
Cognition | 1 | 2018 | 7075 | 0.010 |
Why?
|
Physicians | 1 | 2018 | 4614 | 0.010 |
Why?
|
Blood Glucose | 1 | 1994 | 6430 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 1995 | 14737 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 6085 | 0.010 |
Why?
|
Body Mass Index | 1 | 1997 | 13052 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 9510 | 0.010 |
Why?
|
Hypertension | 1 | 1998 | 8615 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1999 | 862 | 0.010 |
Why?
|
Down-Regulation | 1 | 2005 | 2940 | 0.010 |
Why?
|
Psychotherapy | 1 | 2007 | 1656 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2007 | 6034 | 0.010 |
Why?
|
Whole-Body Irradiation | 1 | 1997 | 435 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2009 | 4411 | 0.010 |
Why?
|
Transduction, Genetic | 1 | 1999 | 902 | 0.010 |
Why?
|
Patient Selection | 1 | 2007 | 4266 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2009 | 12805 | 0.010 |
Why?
|
Sex Factors | 1 | 1986 | 10654 | 0.010 |
Why?
|
Parity | 1 | 1995 | 938 | 0.010 |
Why?
|
Cell Division | 1 | 1999 | 4479 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2008 | 22296 | 0.010 |
Why?
|
Prospective Studies | 1 | 1995 | 54920 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 1996 | 36849 | 0.000 |
Why?
|
Aging | 1 | 1986 | 8764 | 0.000 |
Why?
|
Weight Gain | 1 | 1997 | 2356 | 0.000 |
Why?
|
Child | 1 | 1995 | 80891 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1999 | 11120 | 0.000 |
Why?
|
Cell Differentiation | 1 | 1999 | 11668 | 0.000 |
Why?
|
Longitudinal Studies | 1 | 1997 | 14784 | 0.000 |
Why?
|